Therefore, it is crucial to understand the mechanisms that determine the chemoresistance in RCC, in particular the mechanisms that lead to the p53 inactivation, since TP53 is poorly mutated in RCC as previously illustrated. The gene discussed is TP53; the disease is renal cell carcinoma.